Relay Therapeutics Inc (RLAY) — Capital Reinvestment Ratio

Latest as of March 2021: 0.01x

Relay Therapeutics Inc (RLAY) has a Capital Reinvestment Ratio of 0.01x as of March 2021, meaning it reinvests 0% of its operating cash flow ($46.64 Million) in capital expenditures ($476.00K). Check RLAY intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$46.64 Million

USD

Capital Expenditures

$476.00K

USD

Data as of

Mar 2021

Most recent filing

Annual Capital Reinvestment Ratio for Relay Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Relay Therapeutics Inc from None to None. See RLAY cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow